Total N (%) N=511 | Belgium N (%) N=62 | France N (%) N=343 | Spain N (%) N=106 | p-value | |
---|---|---|---|---|---|
Participation | |||||
Targeted physicians | 1450 | 98 | 1224 | 128 | |
Respondents | 511 (35.2%) | 62 (63.3%) | 343 (28.0%) | 106 (82.8%) | |
Type of physicians (m.d.=0) | |||||
General Practitioners | 491 (96.1%) | 62 (100%) | 343 (100%) | 86 (81.1%) | |
Pediatricians | 20 (3.9%) | 0 | 0 | 20 (18.9%) | |
Sex (m.d.=2) | |||||
Female | 217 (42.6%) | 26 (41.9%) | 131 (38.2%) | 60 (57.7%) | <10−2 |
Male | 292 (57.4%) | 36 (58.1%) | 212 (61.8%) | 44 (42.3%) | |
Age (years) (m.d.=9) | |||||
25-39 | 106 (21.1%) | 3 (4.8%) | 100 (29.9%) | 3 (2.9%) | <10−5 |
40-54 | 114 (22.7%) | 9 (14.5%) | 84 (25.1%) | 21 (20%) | |
≥ 55 | 282 (56.2%) | 50 (80.6%) | 151 (45.1%) | 81 (77.1%) | |
Median (IQR) | 56 (42; 62) | 61 (56; 65) | 52 (37; 60) | 60 (55; 62) | <10−5 |
Practice area (m.d.=3) | |||||
Rural | 149 (29.3%) | 22 (35.5%) | 79 (23%) | 48 (46.6%) | <10−4 |
Urban | 359 (70.7%) | 40 (64.5%) | 264 (77%) | 55 (53.4%) | |
Physicians’ anxiety (m.d.=7) | |||||
Low anxiety feeling | 176 (34.9%) | 24 (38.7%) | 140 (41.3%) | 12 (11.7%) | <10−5 |
Moderate anxiety feeling | 246 (48.8%) | 28 (45.2%) | 164 (48.4%) | 54 (52.4%) | |
High anxiety feeling | 82 (16.3%) | 10 (16.1%) | 35 (10.3%) | 37 (35.9%) | |
Median (IQR) | 4 (2; 6) | 3 (2; 6) | 3 (2; 5) | 6 (4; 7) | <10−5 |
Patients’ anxiety (m.d.=4) | |||||
Low anxiety feeling | 107 (21.1%) | 13 (21%) | 73 (21.3%) | 21 (20.4%) | 0.85 |
Moderate anxiety feeling | 286 (56.4%) | 38 (61.3%) | 188 (55%) | 60 (58.3%) | |
High anxiety feeling | 114 (22.5%) | 11 (17.7%) | 81 (23.7%) | 22 (21.4%) | |
Median (IQR) | 4 (3; 6) | 5 (3; 6) | 5 (3; 6) | 4 (3; 6) | 0.89 |
Risk of seeing infected patients in the next 2 weeks (m.d.=3) | |||||
Low risk | 400 (78.7%) | 46 (74.2%) | 295 (86%) | 59 (57.3%) | <10−5 |
Moderate risk | 97 (19.1%) | 15 (24.2%) | 46 (13.4%) | 36 (35%) | |
High risk | 11 (2.2%) | 1 (1.6%) | 2 (0.6%) | 8 (7.8%) | |
Median (IQR) | 1 (0; 2) | 1 (1; 3) | 1 (0; 2) | 2 (1; 5) | <10−5 |
Finding the measures taken by the health authorities suitable to limit the spread of COVID-19 (m.d.=3) | 409 (80.5%) | 51 (82.3%) | 275 (80.2%) | 83 (80.6%) | 0.93 |
Changes in professional practices (m.d.=4) | 207 (40.8%) | 30 (48.4%) | 124 (36.3%) | 53 (51.5%) | <10−2 |
Impact on consultations (m.d.=3) | 72 (14.2%) | 8 (12.9%) | 39 (11.4%) | 25 (24.3%) | <10−2 |
Types of consequences (m.d.=5) | |||||
Questions about any links with China during consultations | 44 (61.1%) | 4 (50%) | 19 (48.7%) | 21 (84%) | |
Increased consultation time due to question about COVID-19 | 22 (30.6%) | 1 (12.5%) | 14 (35.9%) | 7 (28%) | |
Specific consultations for information on COVID-19 | 6 (8.3%) | 0 | 1 (2.6%) | 5 (20%) | |
Phone calls on COVID-19 | 6 (8.3%) | 2 (25%) | 3 (7.7%) | 1 (4%) | |
Consultations of patients who thought they had contracted COVID-19 | 6 (8.3%) | 1 (12.5%) | 4 (10.3%) | 1 (4%) | |
Anticipation of the epidemic arrival (m.d.=3) | 337 (66.3%) | 40 (64.5%) | 200 (58.3%) | 97 (94.2%) | <10−5 |
Types of anticipation measures (m.d. =32) | |||||
Search of guidelines | 205 (60.8%) | 33 (82.5%) | 113 (56.5%) | 59 (60.8%) | |
Purchase of protection equipment | 122 (36.2%) | 4 (10%) | 63 (31.5%) | 55 (56.7%) | |
Re-use of the influenza pandemic kits | 106 (35.7%) | N.A. | 80 (40%) | 26 (26.8%) | |
Office reorganization to avoid patients’ influx | 60 (17.8%) | 9 (22.5%) | 34 (17%) | 17 (17.5%) | |
Other measures | 13 (3.9%) | 1 (2.5%) | 9 (4.5%) | 3 (3.1%) | |
Level of information regarding the epidemic (m.d.=9) | |||||
Low information level | 80 (16.3%) | 6 (9.6%) | 59 (17.5%) | 15 (14.6%) | 0.05 |
Moderate information level | 168 (33.5%) | 14 (22.6%) | 120 (35.6%) | 34 (33,0%) | |
High information level | 254 (50.6%) | 42 (67.7%) | 158 (46.9%) | 54 (52.4%) | |
Feeling prepared to face the epidemic (m.d.=4) | 229 (45.2%) | 28 (45.2%) | 139 (40.6%) | 62 (60.2%) | <10−2 |